Chinese researchers have developed a wearable dopamine patch that could help monitor depression and Parkinson's disease by ...
Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...
According to Anthropic, scientists often spend a lot of time moving between research databases, coding tools, notebooks and ...
Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...
Taika Waititi’s Sony Pictures adaptation of Ishiguro’s novel hits theaters October 23, 2026, and every technology the book imagined is real. Vision Transformers process images as Klara does — in ...
NFL players face nearly four times higher neurodegenerative disease mortality, with dementia and Parkinson's disease deaths ...
New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...
Teetering near endangered status, the starlet sea anemone produces “an ancient mechanism” for fighting viruses that ...
A research team at the University of Turku in Finland has developed a reliable laboratory model to study BAP1-deficient ...
June studies on NANOG and disease genes highlight potential of base editing and force new discussion on limits of heritable embryo gene editing ...
India is watching the world’s first CRISPR-based leishmaniasis (kala-azar) vaccine trials. Developed by Dr. Satoskar, it aims ...